This inventor holds 3 USPTO granted patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Georgia Research Foundation Inc. Active years: 2012-2013.
Company Filing History:
3 out of 3,688 
1 out of 870 Years Active: 2012-2013
Title: Yossef Raviv: Innovator in Viral Inactivation Technologies
Introduction
Yossef Raviv is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of viral inactivation, holding a total of 3 patents. His work focuses on developing methods that enhance the safety and efficacy of viral preparations used in immunological applications.
Latest Patents
One of Raviv's latest patents involves a method for cellular and viral inactivation. This invention treats viral populations with a compound that crosslinks proteins in the viral membrane, followed by UV irradiation and further inactivation using detergents. This innovative approach preserves the native structure of viral epitopes, allowing the inactivated viral preparations to be utilized in immunological compositions that can inhibit and prevent viral infections when administered to animals. Another significant patent he holds is for compositions of inactivated influenza virus. These compositions are designed to be used as vaccines and immunological formulations that are effective in inhibiting, preventing, and treating influenza.
Career Highlights
Throughout his career, Yossef Raviv has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Georgia Research Foundation Inc. His work has been instrumental in advancing the field of viral inactivation and vaccine development.
Collaborations
Raviv has collaborated with esteemed colleagues such as Mathias D Viard and Robert P Blumenthal. These partnerships have contributed to the success of his innovative projects and patents.
Conclusion
Yossef Raviv's contributions to viral inactivation technologies highlight his role as a leading inventor in the field. His patents not only advance scientific understanding but also have practical applications in public health.